The use of budesonide in the treatment of active Crohn's disease is good clinical practice

Inflammatory Bowel Diseases

Volumn 7, Issue 1, 2001, Pages 60-61

  Sutherland, Lloyd R ^a,c   Van Deventer, S J H ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; BUDENOFALK; BUDESONIDE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MESALAZINE; METHOTREXATE; PLACEBO; PREDNISOLONE; SODIUM;

ACNE; ARTICLE; COLON CROHN DISEASE; COLON SURGERY; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG POTENTIATION; DRUG PULSE THERAPY; DRUG RECEPTOR BINDING; DRUG RELEASE; DRUG RETENTION; DRUG SAFETY; DRUG UPTAKE; FIRST PASS EFFECT; FLUID RETENTION; GOOD CLINICAL PRACTICE; HUMAN; IMMUNOMODULATION; LONG TERM CARE; MOON FACE; PH; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; REMISSION; SIDE EFFECT; SIGNAL TRANSDUCTION; SODIUM RETENTION;

EID: 0035013462     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200102000-00010     Document Type: Article

References (8)

1. A comparison of budesonide and mesalamine for active Crohn's disease
2. Oral budesonide for active Crohn's disease
3. A comparison of budesonide with prednisolone for active Crohn's disease
4. Oral budesonide is as effective as oral prednisolone in active Crohn's disease
5. Budesonide prolongs time to relapse in ileal and ileocecal Crohn's disease. A placebo-controlled one year study
6. Oral budesonide as maintenance treatment of Crohn's disease: A placebo-controlled, dose-ranging study
7. Frequency of glucocorticosteroid resistance and dependency in Crohn's disease
8. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease